You have no items in your shopping cart.
Dog IgG
Description
Research Area
Images & Validation
−| Tested Applications | SDS-PAGE |
|---|---|
| Application Notes |
Key Properties
−| Source | Dog |
|---|---|
| Biological Origin | Dog |
| Isotype | IgG |
| Purity | Dog IgG whole molecule was prepared from normal serum by a multi-step process which includes delipidation, salt fractionation and ion exchange chromatography followed by extensive dialysis against the buffer stated above. Dog IgG whole molecule was assayed by immunoelectrophoresis resulted in a single precipitin arc against anti-Dog IgG and anti-Dog Serum. |
| Conjugation | Unconjugated |
Storage & Handling
−| Storage | Store vial at 4° C prior to restoration. For extended storage aliquot contents and freeze at -20° C or below. Avoid cycles of freezing and thawing. Centrifuge product if not completely clear after standing at room temperature. Dog IgG whole molecule is stable for several weeks at 4° C as an undiluted liquid. Dilute only prior to immediate use. |
|---|---|
| Form/Appearance | Lyophilized |
| Buffer/Preservatives | Preservative: 0.01% (w/v) Sodium Azide; Buffer: 0.02 M Potassium Phosphate, 0.15 M Sodium Chloride, pH 7.2 |
| Concentration | 10.0 mg/mL |
| Disclaimer | For research use only |
Alternative Names
−Similar Products
−Goat Human IgA (Fc specific) Antibody [orb21422]
DOT, ELISA, IF, WB
Human
Goat
Polyclonal
Unconjugated
10 mg

Quality Guarantee
Explore bioreagents carefree to elevate your research. All our products are rigorously tested for performance. If a product does not perform as described on its datasheet, our scientific support team will provide expert troubleshooting, a prompt replacement, or a refund. For full details, please see our Terms & Conditions and Buying Guide. Contact us at [email protected].

Full-length coagulase protein binding to prothrombin, canine IgG, and complement C3. Data were obtained from three independent experiments. (A) ELISA results showing coagulase binding of canine IgG, Fc, and Fab. There was a significant interaction of treatment (IgG, Fc, and Fab) with the binding of coagulase protein (P = 0.010). All three treatments had significant differences between results at different concentrations (P < 0.001). For IgG concentrations of 10, 5, 2.5, and 1.25 µg/ml, binding was significantly different from that of the negative control (*, P < 0.001). For Fc and Fab concentrations of 5 and 10 µg/ml, binding was significantly different from that of the negative control (*, P < 0.001). The coagulase protein bound more IgG and Fc than Fab. At 5 and 10 µg/ml, IgG binding was significantly higher than that of Fab (P = 0.008), and binding of IgG and Fc was marginally different (P = 0.054).

SDS-PAGE of Dog IgG Whole Molecule. Lane 1: Dog IgG Whole Molecule Reduced (10 µg). Lane 2: Dog IgG Whole Molecule Reduced (5 µg). Lane 3: Dog IgG Whole Molecule Reduced (1.0 µg). Lane 4: Opal Prestained Molecular Weight Marker. Lane 5: Dog IgG Whole Molecule Non-Reduced (10 µg). Lane 6: Dog IgG Whole Molecule Non-Reduced (5 µg). Lane 7: Dog IgG Whole Molecule Non-Reduced (1.0 µg). 4-20% Gel, Coomassie Stained.
Quick Database Links
Documents Download
Request a Document
Protocol Information
Dog IgG (orb2652770)
Participating in our Biorbyt product reviews program enables you to support fellow scientists by sharing your firsthand experience with our products.
Login to Submit a Review
